» Articles » PMID: 33258446

is a Haploinsufficient Tumor Suppressor That Limits Telomere Length

Overview
Journal Elife
Specialty Biology
Date 2020 Dec 1
PMID 33258446
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique mutations that truncate TIN2, a shelterin subunit that controls telomere length. Patient lymphocyte telomeres were unusually long. We show that the truncated TIN2 proteins do not localize to telomeres, suggesting that the mutations create loss-of-function alleles. Heterozygous knock-in of the mutations or deletion of one copy of resulted in excessive telomere elongation in clonal lines, indicating that is haploinsufficient for telomere length control. In contrast, telomere protection and genome stability were maintained in all heterozygous clones. The data establish that the truncations predispose to a tumor syndrome. We conclude that acts as a haploinsufficient tumor suppressor that limits telomere length to ensure a timely Hayflick limit.

Citing Articles

Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.

Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.

PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.


Prevalence of pathogenic variants of inborn errors of immunity in critically ill children admitted to the pediatric intensive care unit for sepsis: A Moroccan cohort study.

Aissaoui O, Moundir A, Drissi Boughanbour A, El Bakkouri J, Benhsaien I, Ailal F Tunis Med. 2025; 103(1):93-97.

PMID: 39812200 PMC: 11906231. DOI: 10.62438/tunismed.v103i1.5182.


Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders.

Niewisch M, Kim J, Giri N, Lunger J, McReynolds L, Savage S JAMA Netw Open. 2024; 7(12):e2450111.

PMID: 39661387 PMC: 11635530. DOI: 10.1001/jamanetworkopen.2024.50111.


Telomere function and regulation from mouse models to human ageing and disease.

Jones-Weinert C, Mainz L, Karlseder J Nat Rev Mol Cell Biol. 2024; .

PMID: 39614014 DOI: 10.1038/s41580-024-00800-5.


Different phenotypes with different endings-Telomere biology disorders and cancer predisposition with long telomeres.

Savage S, Bertuch A Br J Haematol. 2024; 206(1):69-73.

PMID: 39462986 PMC: 11739769. DOI: 10.1111/bjh.19851.


References
1.
Frescas D, de Lange T . TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1. Mol Cell Biol. 2014; 34(7):1349-62. PMC: 3993560. DOI: 10.1128/MCB.01052-13. View

2.
Kim S, Kaminker P, Campisi J . TIN2, a new regulator of telomere length in human cells. Nat Genet. 1999; 23(4):405-12. PMC: 4940194. DOI: 10.1038/70508. View

3.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

4.
Haycock P, Burgess S, Nounu A, Zheng J, Okoli G, Bowden J . Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol. 2017; 3(5):636-651. PMC: 5638008. DOI: 10.1001/jamaoncol.2016.5945. View

5.
Taboski M, Sealey D, Dorrens J, Tayade C, Betts D, Harrington L . Long telomeres bypass the requirement for telomere maintenance in human tumorigenesis. Cell Rep. 2012; 1(2):91-8. PMC: 3406325. DOI: 10.1016/j.celrep.2011.12.004. View